NBGAX | VISGX | NBGAX / VISGX | |
Total Expense Ratio | 1.34 | 0.19 | 705% |
Annual Report Gross Expense Ratio | 1.34 | 0.19 | 705% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | -4.364 | 7.310 | -60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.69B | 39.1B | 22% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | -10.71 | 10.18 | -105% |
Returns for 3 years | 3.69 | 49.62 | 7% |
Returns for 5 years | -5.66 | 31.06 | -18% |
Returns for 10 years | -15.25 | 147.79 | -10% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
GMVIX | 16.67 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
RLBCX | 38.75 | 0.04 | +0.10% |
American Funds American Balanced R3 | |||
KSCOX | 163.03 | -0.54 | -0.33% |
Kinetics Small Cap Opportunities No Load | |||
TTISX | 13.81 | -0.09 | -0.65% |
Nuveen Quant Intl Sm Cap Eq Retirement |